News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.


Dear Shareholders,

the Annual General Shareholders’ Meeting of Epigenomics AG has taken place on May 15, 2019 in Berlin. The presence amounted to around 25 % of the share capital. Shareholders approved all amended agenda items according to the Board’s proposal.

Voting results (only in German) PDF
Resolution passed on aganda items 7, 9 and 10 (only in German) PDF


Invitation to the Annual General Shareholders’ Meeting 2019 of Epigenomics AG PDF
Curriculum vitae of Mr Franz Thomas Walt PDF
Reports of the Executive Board on agenda items 6,7, 9 und 10 PDF
Annual Report 2018
(incl. Consolidated Financial Statements, Group Management Report, Supervisory Board Report, Key features of the internal control and risk management system and Remuneration Report)
Financial Statements 2018
(German HGB) incl. Key features of the internal control and risk management system (German version)
Explanatory Report by the Management Board on Disclosures Pusuant to Section 289a (1), Section 315a (1) HGB (German Version) PDF
Information on data protection PDF
Access to the Investor Portal of Epigenomics AG Link


Corporate Governance/Declaration of Governance

Declaration of Compliance with the German Corporate Governance Code pursuant to Section 161 of the German Stock Corporation Act (AktG) PDF
Declaration of Governance and reporting on Corporate Governance pursuant to Section 289a German Commercial Code (HGB) PDF


Further information

Explanation of Shareholders’ rights PDF
Articles of Association PDF


Counterproposal regarding agenda items 4, 5, 6, 7, 9 and 10 (only in German) PDF
Statement by the Supervisory Board regarding the counter-motions of DELPHI Unternehmensberatung AG on agenda items 4 and 5 PDF